Former Netflix Exec Sues After Losing a $1.1 Million Job, Says Medically Prescribed Ketamine Disclosure L

Key Points:

• Kevin Baillie, former Netflix-owned Eyeline Studios VP, sued Netflix claiming he was fired after disclosing his physician-supervised ketamine therapy for depression during a company retreat trust exercise.
• The lawsuit alleges Netflix investigated Baillie’s ketamine treatment comments with suspicion of recreational drug use and that this issue factored into his termination, along with denial of severance pay.
• Baillie also accuses Netflix of a double standard regarding workplace drinking culture, citing CEO Jeff Shapiro’s alcohol-friendly behavior and tolerance of profanity, contrasting with scrutiny on Baillie’s conduct.
• Separately, Netflix reported Q2 revenue of $12.56 billion, slightly below expectations, but earnings per share beat estimates; Q3 revenue guidance also fell short of analyst consensus despite anticipated growth.
• Netflix shares rose 1.74% to $70.09 following the earnings report, reflecting mixed investor reaction amid ongoing legal and operational developments.